Overcoming Barriers to Immune Therapy in Melanoma

Recognized experts in the field of melanoma research gathered for this one-day symposium located at the Moores Cancer Center, University of California in La Jolla, California on November 11, 2006.  Melanoma affects 1 in 35 individuals during their lifetime.  Immune-based therapies are being developed for metastatic melanoma, a form of the cancer for which excision of the melanoma lesions is ineffective.  The scientific committee assembled a unique group of basic and clinical oncologists, who presented the state-of-the-art in immune-based treatments for malignant melanomas.  The program agenda allowed for networking and scientific discussion among junior scientists and senior faculty.  Complimentary lunch and refreshments during session breaks was provided.